Record stringlengths 1 197k |
|---|
Compared to Nasogastric Tube Feeding, can the Intermittent Oro-esophageal Tube Feeding better improve the nutritional status, extubation of tracheostomy tube, pulmonary infection, neurological deficit of Patients with Intracerebral Hemorrhage Compared to Nasogastric Tube Feeding, is the Intermittent Oro-esophageal Tube... |
Participants will be divided into two groups randomly, with different nutritional support respectively. conditions: Intracerebral Hemorrhage studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: SINGLE whoMasked: OUTCOMES_ASSESSOR count: 120 type: EST... |
<|newrecord|> nctId: NCT06328933 id: IOE feeding amount briefTitle: Intermittent Oral Tube on Feeding Amount overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2024-12 date: 2024-12 date: 2024-03-25 date: 2024-03-25 name: Copka Sonpashan class: OTHER_GOV briefSummary: The goal of this clinical trial is to compare th... |
<|newrecord|> nctId: NCT06328920 id: IOE Yicongxing briefTitle: Intermittent Oro-esophageal Tube on Rehabilitation Therapy Compliance for Stroke overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2024-12 date: 2024-12 date: 2024-03-25 date: 2024-03-25 name: Copka Sonpashan class: OTHER_GOV briefSummary: The aim of t... |
<|newrecord|> nctId: NCT06328907 id: IOE Social Condition briefTitle: Multifunctional Nutrition Tube on Social Condition and Experience in Cerebralvascular Accident overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2024-12 date: 2024-12 date: 2024-03-25 date: 2024-03-25 name: Copka Sonpashan class: OTHER_GOV briefS... |
<|newrecord|> nctId: NCT06328894 id: IOE Psychological briefTitle: Effect of Different Feeding Modes on Psychological Condition and Experience in Stroke Patients overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2024-12 date: 2024-12 date: 2024-03-25 date: 2024-03-25 name: Copka Sonpashan class: OTHER_GOV briefSumm... |
<|newrecord|> nctId: NCT06328881 id: IOE Parkinson briefTitle: Effect of Intermittent Oral Tube on Dysphagia in Parkinson's Disease Patients overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2024-12 date: 2024-12 date: 2024-03-25 date: 2024-03-25 name: Copka Sonpashan class: OTHER_GOV briefSummary: The goal of this... |
• Can stellate ganglion block improve the nutritional status, dysphagia, and activities of daily living in patients with Parkinson's disease, better than Nasogastric Tube Feeding. |
Participants will be divided into the control group and observation group evenly. All the patients were provided with routine therapy and given nutritional support by Intermittent Oro-esophageal Tube Feeding and Nasogastric Tube Feeding respectively. The nutritional status, swallowing function, and activities of daily ... |
<|newrecord|> nctId: NCT06328868 id: IOE Nasopharyngeal Carcinoma briefTitle: Multifunctional Nutrition Tube in Dysphagia for Nasopharyngeal Carcinoma overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2024-12 date: 2024-12 date: 2024-03-25 date: 2024-03-25 name: Copka Sonpashan class: OTHER_GOV briefSummary: Baseli... |
Palliation to delayed dysphagia after radiotherapy for nasopharyngeal carcinoma (NPC) continues to be a challenge. Although nasogastric tube feeding (NGT) has been adopted widely, the weaknesses have yet to be improved by another enteral nutrition support mode. This study aims to observe the clinical efficacy of interm... |
<|newrecord|> nctId: NCT06328855 id: IOE Dysphagia in Stroke briefTitle: Intermittent Oro-esophageal Tube Feeding on Dysphagia in Stroke Survivor overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2024-12 date: 2024-12 date: 2024-03-25 date: 2024-03-25 name: Copka Sonpashan class: OTHER_GOV briefSummary: This was a ... |
<|newrecord|> nctId: NCT06328842 id: IOE Cerebral Small Vessel briefTitle: Effect of Multifunctional Nutrition Tube on Cerebral Small Vessel Disease Patients overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2024-12 date: 2024-12 date: 2024-03-25 date: 2024-03-25 name: Copka Sonpashan class: OTHER_GOV briefSummary:... |
<|newrecord|> nctId: NCT06328829 id: IOE Alzheimer briefTitle: Intermittent Oral Tube in Alzheimer's Patients overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2024-12 date: 2024-12 date: 2024-03-25 date: 2024-03-25 name: Copka Sonpashan class: OTHER_GOV briefSummary: This is a prospective multicenter study with Al... |
<|newrecord|> nctId: NCT06328816 id: Computer-based Training briefTitle: Computer-based Training on Cognitive Dysphagia in Stroke Survivors overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2024-12 date: 2024-12 date: 2024-03-25 date: 2024-03-25 name: Copka Sonpashan class: OTHER_GOV briefSummary: This is a multice... |
<|newrecord|> nctId: NCT06328803 id: Active Breathing Exercises briefTitle: Impact of Active Breathing Exercises on Respiratory Rhythm Disorders in Stroke Patients overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2024-12 date: 2024-12 date: 2024-03-25 date: 2024-03-25 name: Copka Sonpashan class: OTHER_GOV briefSu... |
<|newrecord|> nctId: NCT06328790 id: PNRR-MAD-2022-12376826 briefTitle: Study of Biomorkers and Rehabilitation Strategies in Functional Motor Disorders (FMD) overallStatus: RECRUITING date: 2023-05-31 date: 2025-05 date: 2025-05 date: 2024-03-25 date: 2024-03-26 name: Michele Tinazzi, MD, PhD class: OTHER name: IRCCS O... |
<|newrecord|> nctId: NCT06328777 id: CAB-201-003 briefTitle: RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis overallStatus: NOT_YET_RECRUITING date: 2024-06 date: 2029-07 date: 2029-07 date: 2024-03-25 date: 2024-04-26 name: ... |
<|newrecord|> nctId: NCT06328764 id: CS-101-11 briefTitle: A Clinical Trial Evaluating the Safety and Efficacy of CS-101 in Treating Subjects With β-thalassemia overallStatus: NOT_YET_RECRUITING date: 2024-03-20 date: 2025-12-31 date: 2026-01-30 date: 2024-03-25 date: 2024-03-25 name: CorrectSequence Therapeutics Co., ... |
<|newrecord|> nctId: NCT06328751 id: 76043823.0.0000.0004 briefTitle: Meditation With Virtual Reality for Cancer Pain Relief in the Pain Therapy and Palliative Care Service overallStatus: NOT_YET_RECRUITING date: 2024-03-31 date: 2025-06-30 date: 2025-08-30 date: 2024-03-25 date: 2024-03-25 name: Emily Santos Montarroy... |
<|newrecord|> nctId: NCT06328738 id: ELVN-002-003 briefTitle: ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer overallStatus: RECRUITING date: 2024-06-01 date: 2027-01 date: 2028-07 date: 2024-03-25 date: 2024-03-26 name: Enliven Therapeutics class: INDUSTRY briefSummary: T... |
<|newrecord|> nctId: NCT06328725 id: EN001_POWER briefTitle: Evaluate the Efficacy and Safety of EN001 in Patients With Duchenne Muscular Dystrophy overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2025-11 date: 2025-11 date: 2024-03-25 date: 2024-03-25 name: ENCell class: INDUSTRY briefSummary: A Multi-center, Ran... |
\<Phase 2 Clinical Trial\> A total of 76 participants (a minimum of 30 participants per group, considering a dropout rate of 20%, resulting in 38 participants per group). primaryPurpose: TREATMENT masking: DOUBLE maskingDescription: The investigational drug for the clinical trial of the following cohort or group will b... |
\<Phase 1 Clinical Trial\> Cohort 1: EN001 5.0x10\^5 cells/kg / Cohort 2: EN001 2.5x10\^6 cells/kg |
\<Phase 2 Clinical Trial\> Experimental Group: Recommended Phase 2 Dose (RP2D) for EN001 / Control Group: Placebo for EN001 whoMasked: PARTICIPANT whoMasked: INVESTIGATOR count: 88 type: ESTIMATED name: EN001 measure: <Phase 1> Adverse drug reactions related to dose limiting toxicity (DLT) measure: <Phase 1> Adverse dr... |
<|newrecord|> nctId: NCT06328712 id: EN001_MIRACLE1 briefTitle: Evaluate the Safety and Efficacy of EN001 in Patients With Charcot-Marie-Tooth Disease Type 1A overallStatus: RECRUITING date: 2024-03 date: 2024-10 date: 2024-10 date: 2024-03-25 date: 2024-03-25 name: ENCell class: INDUSTRY briefSummary: An Open, Dose-es... |
<|newrecord|> nctId: NCT06328699 id: STUDY00006456 id: EU6011-23 type: OTHER domain: Emory University Hospital/Winship Cancer Institute id: K01AT010488 type: NIH link: https://reporter.nih.gov/quickSearch/K01AT010488 id: P30CA138292 type: NIH link: https://reporter.nih.gov/quickSearch/P30CA138292 briefTitle: Chaplain-D... |
<|newrecord|> nctId: NCT06328686 id: STUDY00005787 id: NCI-2023-10895 type: REGISTRY domain: CTRP (Clinical Trial Reporting Program) id: STUDY00005787 type: OTHER domain: Emory University Hospital/Winship Cancer Institute id: WINSHIP5883-23 type: OTHER domain: Emory University Hospital/Winship Cancer Institute id: P30C... |
<|newrecord|> nctId: NCT06328673 id: DM919-001 briefTitle: A Study of DM919 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors overallStatus: RECRUITING date: 2024-03-01 date: 2025-12-01 date: 2026-03-01 date: 2024-03-25 date: 2024-03-28 name: D2M Biotherapeutics Inc. class: INDUSTRY briefSummary: The... |
The main questions it aims to answer are: |
What is the safe and effective dose of DM919 when used alone or in combination with pembrolizumab? What cancers can be treated effectively with DM919 alone or in combination with pembrolizumab?? |
Participants will be asked to attend clinic and be given a intravenous infusion of DM919 or DM-919 in combination with pembrolizumab. They will have blood tests and other assessments to measure whether DM-919 will have the effect on tumors. conditions: Advanced Solid Tumor studyType: INTERVENTIONAL phases: PHASE1 alloc... |
<|newrecord|> nctId: NCT06328660 id: EX-MKTG-155 briefTitle: Refitting Multifocal Contact Lens Wearers With a Different Multifocal Contact Lens overallStatus: ACTIVE_NOT_RECRUITING date: 2024-02-15 date: 2024-06-18 date: 2024-06-18 date: 2024-03-25 date: 2024-03-25 name: Coopervision, Inc. class: INDUSTRY briefSummary:... |
<|newrecord|> nctId: NCT06328647 id: 24-010 briefTitle: Quantra Point-of-Care Hemostasis Monitoring acronym: QUANTRA overallStatus: NOT_YET_RECRUITING date: 2024-05-01 date: 2026-12-31 date: 2026-12-31 date: 2024-03-25 date: 2024-04-23 name: The Cleveland Clinic class: OTHER briefSummary: The investigators will test th... |
<|newrecord|> nctId: NCT06328634 id: LOCAL/2014/FV-01 briefTitle: Bacillus Cereus Infection of Patients Diagnosed at Nîmes University Hospital overallStatus: COMPLETED date: 2008-01-01 date: 2012-12-31 date: 2012-12-31 date: 2024-03-25 date: 2024-03-25 name: Centre Hospitalier Universitaire de Nīmes class: OTHER briefS... |
We aimed to study the characteristics of patients presenting with a Bacillus cereus infection in a university hospital. |
METHODS: |
We performed a retrospective analysis of the clinical, biological, and treatment-related data of patients hospitalized in our university hospital between January 1st, 2008 and December 31st, 2012 and diagnosed with a B. cereus infection. We identified a subgroup of patients presenting with bacteremia and looked for ris... |
<|newrecord|> nctId: NCT06328621 id: 19594 id: NCI-2021-05881 type: REGISTRY domain: CTRP (Clinical Trial Reporting Program) id: 19594 type: OTHER domain: City of Hope Medical Center id: P30CA033572 type: NIH link: https://reporter.nih.gov/quickSearch/P30CA033572 briefTitle: Lung Cancer Risk Assessment and Etiology ove... |
<|newrecord|> nctId: NCT06328608 id: CLI-06657AA1-01 id: 2022-503128-29 type: REGISTRY domain: Clinical Trial Information System (CTIS) - EU briefTitle: A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease acronym: FLY overallStatus: NOT_YET_RECRUITING d... |
<|newrecord|> nctId: NCT06328595 id: Cross sectional briefTitle: Muscular and Joint Symptoms in COVID-19 Patients: Insights From Syria overallStatus: COMPLETED date: 2022-04-22 date: 2023-05-04 date: 2023-08-20 date: 2024-03-25 date: 2024-03-26 name: Syrian Private University class: OTHER briefSummary: Observation stud... |
<|newrecord|> nctId: NCT06328582 id: Zhenjiu Post-stroke dysphagia briefTitle: Acupuncture Technique for Restoring Consciousness on Post-stroke Dysphagia overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2024-12 date: 2024-12 date: 2024-03-25 date: 2024-03-25 name: Copka Sonpashan class: OTHER_GOV briefSummary: Thi... |
<|newrecord|> nctId: NCT06328569 id: VR Wallenberg Syndrome briefTitle: Virtual Reality Therapy on Dysphagia in Wallenberg Syndrome overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2024-12 date: 2024-12 date: 2024-03-25 date: 2024-03-25 name: Copka Sonpashan class: OTHER_GOV briefSummary: The goal of this clinical... |
the efficacy of Virtual Reality Therapy in the rehabilitation of patients with dysphagia in Wallenberg syndrome. |
Participants received conventional dysphagia treatment and Virtual Reality Therapy once a day for 14 days. Researchers compared the control group to see the effect and mechanism of Virtual Reality Therapy. conditions: Wallenberg Syndrome studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PAR... |
<|newrecord|> nctId: NCT06328556 id: Ultrasound-guided Botulinum briefTitle: Ultrasound-guided Botulinum Toxin Injection on Cricopharyngeal Muscle Dysfunction overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2024-12 date: 2024-12 date: 2024-03-25 date: 2024-03-25 name: Copka Sonpashan class: OTHER_GOV briefSummary... |
<|newrecord|> nctId: NCT06328543 id: N-20210046 4th project briefTitle: Itch Sensation Induced by Multiple Applications of Pruritogens (Temporal Summation) overallStatus: NOT_YET_RECRUITING date: 2024-04-01 date: 2025-12-31 date: 2026-12-31 date: 2024-03-25 date: 2024-03-25 name: Aalborg University class: OTHER briefSu... |
<|newrecord|> nctId: NCT06328530 id: N-20210046 3rd project briefTitle: Itch Sensation Induced by Simultaneous Application of Pruritogens (Spatial Summation) overallStatus: NOT_YET_RECRUITING date: 2024-04-01 date: 2025-12-31 date: 2026-12-31 date: 2024-03-25 date: 2024-03-25 name: Aalborg University class: OTHER brief... |
<|newrecord|> nctId: NCT06328517 id: 2023-305 briefTitle: The Influence of Nutritional Factors on the Prognosis of Liver Cirrhosis Patients and the Exploration of Predictive Models overallStatus: RECRUITING date: 2023-11-01 date: 2026-11-01 date: 2026-11-01 date: 2024-03-25 date: 2024-03-25 name: Juan Kang class: OTHER... |
Therefore, malnutrition should be treated as equally important complications such as ascites and hepatic encephalopathy, and accurate screening, evaluation and appropriate nutritional intervention measures should be taken to improve the prognosis of patients with Cirrhosis. This study aims to establish a nomogram model... |
<|newrecord|> nctId: NCT06328504 id: Cashew Protocol briefTitle: Efficacy of Cashew Nut Protein Immunotherapy overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2026-04-21 date: 2027-04-21 date: 2024-03-25 date: 2024-03-25 name: Medical University of Warsaw class: OTHER briefSummary: It is a randomized, sigle-center... |
<|newrecord|> nctId: NCT06328491 id: OZUHN-014 id: 22-5325 type: OTHER domain: University Health Network briefTitle: Erdafitinib in Metastatic Steroid-cell Ovarian Cancer overallStatus: COMPLETED date: 2022-05-30 date: 2022-08-22 date: 2022-08-22 date: 2024-03-25 date: 2024-03-25 name: University Health Network, Toront... |
<|newrecord|> nctId: NCT06328478 id: Predictors of AKI in PICU. briefTitle: Predictors of Acute Kidney Injury in Critically Ill Children Admitted to PICU. overallStatus: NOT_YET_RECRUITING date: 2024-05-01 date: 2025-04-01 date: 2025-05-01 date: 2024-03-25 date: 2024-04-16 name: Assiut University class: OTHER briefSumm... |
<|newrecord|> nctId: NCT06328465 id: IEO 1108 briefTitle: fREEDOM: REsonance for Early Detection Of Breast Cancer Metastases acronym: fREEDOM overallStatus: RECRUITING date: 2019-11-22 date: 2028-12-31 date: 2028-12-31 date: 2024-03-25 date: 2024-03-25 name: European Institute of Oncology class: OTHER briefSummary: The... |
<|newrecord|> nctId: NCT06328452 id: MASLD briefTitle: Risk Factors and Impact MASLD in Patients With IBD acronym: MASLD overallStatus: NOT_YET_RECRUITING date: 2024-04-01 date: 2024-06-30 date: 2025-06-30 date: 2024-03-25 date: 2024-03-25 name: Assiut University class: OTHER briefSummary: Inflammatory bowel disease (I... |
In about 5-50% of patients with IBD, there are several extraintestinal manifestations as primary sclerosing cholangitis, autoimmune/granulomatous hepatitis, and non-alcoholic fatty liver disease (NAFLD). |
Metabolic dysfunction-associated steatotic liver disease "MASLD"(formerly NAFLD) is a spectrum of hepatic diseases associated with metabolic and cardiovascular disorders, such as obesity, insulin resistance (IR), hypertension, dyslipidemia, impaired glucose tolerance and type 2 diabetes mellitus. |
The risk factors of developing liver steatosis in patients with IBD remain undetermined. Some studies have supported traditional risk factors, such as type 2 Diabetes mellitus (T2DM), weight gain, or obesity, to contribute to MAFLD development in patients with IBD. Other studies have highlighted the involvement of dise... |
Limited data are available on the frequency and risk factors of MASLD in Egyptian patients with IBD, and no published Egyptian study has addressed the clinical utility of serum steatosis markers in MASLD prediction in IBD population. Moreover, the impact of MASLD on IBD course is unclear. Therefore, we will conduct our... |
<|newrecord|> nctId: NCT06328439 id: ANS014004-I-CN-01 briefTitle: A Study to Evaluate ANS014004 in Subjects With Locally Advanced or Metastatic Solid Tumors overallStatus: RECRUITING date: 2024-03-19 date: 2027-12-31 date: 2028-01-31 date: 2024-03-25 date: 2024-03-25 name: Avistone Biotechnology Co., Ltd. class: INDUS... |
* The study consists of two parts: a dose-escalation part (Part 1) and a dose-expansion part (Part 2). For each subject, the study will consist of a screening period (Day -28 to Day -1), a treatment period (until discontinuation of treatment) and a follow-up period (including safety follow-up and survival follow-up). |
* During the Treatment Period, subjects will receive ANS014004 single-agent oral administration until the subject meets any treatment termination criteria. |
1, The dose-escalation part (Part 1) will consist of a single-dose period and a multiple-dose period (28 days per cycle), participants during dose escalation will receive a single dose of ANS014004 on Day 1 of the single-dose period in order to obtain complete PK parameters for the single dose. There will be a 7-day wa... |
2. In the Dose Expansion (Part 2), participants, will receive oral administration of ANS014004 QD at each treatment cycle (28 days per cycle). An end-of-treatment (EOT) visit will be conducted within 7 days of the final dose or investigator decision to discontinue. |
All subjects will undergo imaging evaluations of their tumors every 8 weeks until disease progression is confirmed by the investigator, the subject begins new antitumor therapy, dies, is lost to follow-up, or withdraws from the study, whichever occurs first. conditions: Locally Advanced or Metastatic Solid Tumors study... |
<|newrecord|> nctId: NCT06328426 id: Anti-osteoarthritis briefTitle: Vitamin D With Omega-3 or Metformin in Osteoarthritis overallStatus: NOT_YET_RECRUITING date: 2024-08 date: 2026-08 date: 2026-12 date: 2024-03-25 date: 2024-03-25 name: Assiut University class: OTHER briefSummary: To determine the efficacy of vitamin... |
<|newrecord|> nctId: NCT06328413 id: KAEK-302 briefTitle: L-PRF vs PBM on Extraction Socket Healing overallStatus: COMPLETED date: 2020-04-20 date: 2021-06-21 date: 2021-09-21 date: 2024-03-25 date: 2024-03-25 name: Akdeniz University class: OTHER briefSummary: The aim of this study is to compare leukocyte and platelet... |
<|newrecord|> nctId: NCT06328400 id: VV116-RSV-02 briefTitle: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Deuremidevir Hydrobromide for Suspension overallStatus: RECRUITING date: 2024-03-27 date: 2024-06-30 date: 2024-08-30 date: 2024-03-25 date: 2024-04-24 name: Vigonvita Life Sciences c... |
<|newrecord|> nctId: NCT06328387 id: SYSKY-2024-064-03 briefTitle: HCQ+ADC vs ADC in the Treatment of Advanced Breast Cancer overallStatus: RECRUITING date: 2024-01-29 date: 2026-02-01 date: 2026-03-01 date: 2024-03-25 date: 2024-03-25 name: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University class: OTHER briefSumm... |
Therefore,we envisage that Trastuzumab Deruxtecan(T-DXd) or Sacituzumab Govitecan (SG) combined with hydroxychloroquine(HCQ) in the treatment of advanced breast cancer in clinical practice has the advantages of improving efficacy and survival. |
To this end, we intend to conduct a prospective,multi-center, phase I/II clinical trial to evaluate the efficacy and safety of T-DXd or SG in combination with HCQ in patients with advacned breast cancer. conditions: Advanced Breast Cancer conditions: Metastatic Breast Cancer studyType: INTERVENTIONAL phases: PHASE1 pha... |
1. arm A: SG. |
2. arm B: HCQ+SG. |
3. arm C: T-DXd . |
4. arm D: HCQ+T-DXd. primaryPurpose: TREATMENT masking: NONE count: 120 type: ESTIMATED name: Hydroxychloroquine name: Sacituzumab Govitecan name: Trastuzumab Deruxtecan measure: Dose Limiting Toxicity, DLT measure: Adverse event, AE measure: Objective Response Rate, ORR measure: Progression-Free Survival, PFS measure:... |
<|newrecord|> nctId: NCT06328374 id: 240420 briefTitle: Voice and Swallowing Disorders in Adults With and Without Alzheimer's Disease overallStatus: NOT_YET_RECRUITING date: 2024-05 date: 2026-03 date: 2026-12 date: 2024-03-25 date: 2024-03-26 name: Vanderbilt University Medical Center class: OTHER briefSummary: This r... |
Healthy adults and individuals with Alzheimer's disease will: |
* undergo tests of cough, voice, and swallow function |
* undergo tests of grip and tongue strength |
* complete questionnaires |
Caregivers of individuals with Alzheimer's disease will also complete questionnaires. conditions: Alzheimer Disease conditions: Caregiver Burden conditions: Healthy Aging conditions: Dysphonia conditions: Dysphagia studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 120 type: ESTIMAT... |
<|newrecord|> nctId: NCT06328361 id: R24008 briefTitle: Nordic ORgan Preservation Pilot Approach Nonrandomised Single-Arm Trial for Non-Operative Management of Rectal Cancer acronym: NORPPA-1 overallStatus: NOT_YET_RECRUITING date: 2024-05-01 date: 2028-12-31 date: 2032-12-31 date: 2024-03-25 date: 2024-03-25 name: Tam... |
* if the oncological results of nonoperative management after Nordic practice in chemoradiotherapy indications differ from experiences elsewhere |
* what is the organ preservation rate |
* what is the local regrowth rate conditions: Rectal Cancer conditions: Rectal Adenocarcinoma studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT masking: NONE count: 200 type: ESTIMATED name: Nonoperative surveillance measure: Disease-free survival measure: Ove... |
<|newrecord|> nctId: NCT06328348 id: SW010 briefTitle: Assessing the Synergistic Effects of Black Cohosh, Soy Isoflavones, and SDG Lignans (Soloways TM) on Menopausal Symptoms overallStatus: COMPLETED date: 2023-07-18 date: 2023-11-30 date: 2023-12-30 date: 2024-03-25 date: 2024-03-25 name: S.LAB (SOLOWAYS) class: OTHE... |
The trial involved 96 eligible women from the Center for New Medical Technologies registry in Novosibirsk, Russia, divided into two groups through a computer-generated random sequence. One group received the active supplements, while the other received a placebo, with both groups and researchers blinded to the assignme... |
The study's design also included measures to ensure adherence and minimize bias, such as drug container returns and daily reminders. The involvement of S.Lab (Soloways) was limited to manufacturing the supplements, with the research conducted independently to avoid commercial influence. The sample size calculation indi... |
<|newrecord|> nctId: NCT06328335 id: Orthostatic Hypotension briefTitle: The Effect of Rehabilitation Training on Orthostatic Hypotension in Parkinson's Patients overallStatus: NOT_YET_RECRUITING date: 2024-04 date: 2024-12 date: 2024-12 date: 2024-03-25 date: 2024-03-25 name: Copka Sonpashan class: OTHER_GOV briefSumm... |
Can raise-bed training improve Orthostatic Hypotension in Parkinson's Patients. Patients will be randomly allocated into the control group or the experimental group, all under rehabilitation treatment, the experimental group will be given raise-bed training. The study lasts 21 days for each patient. Researchers will co... |
<|newrecord|> nctId: NCT06328322 id: Soh-Med-24-03-02MD briefTitle: Study of Percutaneous Coronary Intervention in Left Main Coronary Artery Disease in Patients With Acute Coronary Syndrome at Sohag University Hospitals overallStatus: RECRUITING date: 2024-04-01 date: 2025-04-01 date: 2025-04-01 date: 2024-03-25 date: ... |
The left main coronary artery (LMCA) is responsible for supplying a substantial portion of the left ventricular myocardium, including the interventricular septum and the anterior and lateral walls. Any obstruction or compromise in blood flow within this critical artery can have severe consequences, including myocardial... |
Among the various coronary arteries affected by atherosclerosis, left main coronary artery disease (LMCAD) holds particular clinical significance due to its anatomical location and the vital role it plays in supplying a substantial portion of the left ventricular myocardium. The left main coronary artery (LMCA) typical... |
The selection of an appropriate treatment strategy for LMCAD associated with ACS is a complex decision that requires careful consideration of multiple factors, including patient characteristics, coronary anatomy, severity of ischemia, and procedural expertise. The emergence of several clinical trials and observational ... |
<|newrecord|> nctId: NCT06328309 id: Myofascial Traumatic Brain briefTitle: Impact of v Release on Dysphagia in Patients With Traumatic Brain Injury overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2024-12 date: 2024-12 date: 2024-03-25 date: 2024-03-25 name: Copka Sonpashan class: OTHER_GOV briefSummary: The goal... |
• Can Myofascial Release Therapy improve swallowing function in Traumatic Brain injured Survivors? Patients will be randomly allocated into the control group or the experimental group, all under rehabilitation treatment, the experimental group will be given Myofascial Release Therapy. The study lasts 21 days for each p... |
<|newrecord|> nctId: NCT06328296 id: Myofascial Parkinson's Dysphag briefTitle: Impact of Myofascial Release on Dysphagia in Parkinson's Disease Patients overallStatus: NOT_YET_RECRUITING date: 2024-04 date: 2024-12 date: 2024-12 date: 2024-03-25 date: 2024-03-25 name: Copka Sonpashan class: OTHER_GOV briefSummary: The... |
• Can Myofascial Release Therapy improve swallowing function in Parkinson's Patients? Patients will be randomly allocated into the control group or the experimental group, all under rehabilitation treatment, the experimental group will be given Myofascial Release Therapy. The study lasts 21 days for each patient. Resea... |
<|newrecord|> nctId: NCT06328283 id: Soh-Med-24-02-01MD briefTitle: The Diagnostic Efficacy of Glutamine Synthetaseand BCLAF1in Early Diagosis of Hepatocellular Carcinoma in Cirrhotic Patients overallStatus: NOT_YET_RECRUITING date: 2024-04-01 date: 2026-03-01 date: 2026-03-01 date: 2024-03-25 date: 2024-03-25 name: So... |
HCC incidences arise in complications associated with chronic liver disease like cirrhosis, endemic hepatitis B virus (HBV)/hepatitis C virus (HCV) infections, non alcoholic fatty liver disease (NAFLD), and alcohol-related liver disease (Torre, 2015). conditions: Hepatocellular Carcinoma studyType: OBSERVATIONAL observ... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.